---
figid: PMC6767550__MED-39-1447-g002
figlink: /pmc/articles/PMC6767550/figure/med21557-fig-0002/
number: F2
caption: Canonical and noncanonical signaling pathways of NOD1 and NOD2. A, B, NF‐κB
  and MAPK signaling pathways. NOD1 and NOD2 recognize bacterial PGN fragments, iE‐DAP
  and MDP, respectively. After ligand recognition, NODs undergo conformational changes
  and self‐oligomerization through homophilic CARD‐CARD interactions, allowing the
  recruitment and activation of the adaptor protein RIPK2. In an established protein
  complex, RIPK2 is polyubquitinated by TRAFs and cIAPs, allowing the recruitment
  of polyubiquitinated NEMO or TAK1 to the established protein complex. On one hand,
  NEMO triggers activation of the NF‐κB pathway by phosphorylation of IκB resulting
  in release NF‐κB transcription factor. The latter translocates to the nucleus where
  causes induction of pro‐inflammatory genes. On the other hand, TAK1 recruits TAB1/2/3
  activating both NF‐κB and MAPK pathway (JNK, ERK, and p38). Activated MAPKs translocate
  to the nucleus and activate AP‐1 transcription factor resulting transcription of
  genes involved in inflammatory response. C, Apoptosis pathway. NODs have been reported
  to interact with the apoptotic pathway indirectly through IAP family of proteins
  (cIAP1, cIAP2, and XIAP) and proapoptotic protein Bid. D, Inflammasome activation.
  NODs associate with several other NLRs (NLRP1 and NLRP3) to form inflammasome protein
  complexes. After detection of their cognate ligand, NLRs interact with ASC protein
  and procaspase‐1, resulting in formation of inflammasomes. Once formed, inflammasomes
  activate procaspase‐1, which in turn proteolytically processes pro‐inflammatory
  cytokines IL‐1β and IL‐18. E, Autophagy. Activated NODs recruit the autophagy protein
  ATG16L1 to the cell membrane and facilitate the formation of autophagosome around
  invading bacteria. F, Antiviral response. Viral ssRNA activates NOD2, which translocates
  to the mitochondria and supposedly binds to MAVS. This promotes formation of a complex
  with TBK1 and IKKα, which enables activation of interferon regulatory factor (IRF)
  3 resulting in production of IFN type I. ASC, apoptosis‐associated speck‐like protein
  containing caspase recruitment domain; CARD, caspase recruitment domain; cIAP, cellular
  inhibitor of apoptosis protein; ERK, extracellular signal‐regulated kinase; IAP,
  inhibitor of the apoptosis; iE‐DAP, d‐glutamyl‐meso‐diaminopimelic acid; IFN, interferon;
  IKK, IκB kinase; IκB, protein inhibitor of NF‐κB; IL, interleukin; JNK, c‐Jun N‐terminal
  kinase; NOD, nucleotide‐binding oligomerization domain; NF‐κB, nuclear factor κB;
  MAPK, mitogen‐associated protein kinase; MAVS, mitochondrial antiviral signaling;
  MDP, muramyl dipeptide; NEMO, nuclear factor κB essential modulator; NLRs, nucleotide‐binding
  oligomerization domain‐like receptors; PGN, peptidoglycan; RIPK2, receptor‐interacting
  serine/threonine‐protein kinase 2; TAB, transforming growth factor binding protein;
  TAK1, transforming growth factor β‐activated kinase 1; TBK1, TRAF‐associated nuclear
  factor‐κB activator–binding kinase 1; TRAFs, tumor necrosis factor receptor–associated
  factors; XIAP, X‐linked inhibitor of apoptosis protein [Color figure can be viewed
  at wileyonlinelibrary.com]
pmcid: PMC6767550
papertitle: Harnessing the untapped potential of nucleotide‐binding oligomerization
  domain ligands for cancer immunotherapy.
reftext: Sanja Nabergoj, et al. Med Res Rev. 2019 Sep;39(5):1447-1484.
pmc_ranked_result_index: '69371'
pathway_score: 0.928824
filename: MED-39-1447-g002.jpg
figtitle: Canonical and noncanonical signaling pathways of NOD1 and NOD2
year: '2019'
organisms:
- Homo sapiens
ndex: a26a6fc3-df0b-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6767550__MED-39-1447-g002.html
  '@type': Dataset
  description: Canonical and noncanonical signaling pathways of NOD1 and NOD2. A,
    B, NF‐κB and MAPK signaling pathways. NOD1 and NOD2 recognize bacterial PGN fragments,
    iE‐DAP and MDP, respectively. After ligand recognition, NODs undergo conformational
    changes and self‐oligomerization through homophilic CARD‐CARD interactions, allowing
    the recruitment and activation of the adaptor protein RIPK2. In an established
    protein complex, RIPK2 is polyubquitinated by TRAFs and cIAPs, allowing the recruitment
    of polyubiquitinated NEMO or TAK1 to the established protein complex. On one hand,
    NEMO triggers activation of the NF‐κB pathway by phosphorylation of IκB resulting
    in release NF‐κB transcription factor. The latter translocates to the nucleus
    where causes induction of pro‐inflammatory genes. On the other hand, TAK1 recruits
    TAB1/2/3 activating both NF‐κB and MAPK pathway (JNK, ERK, and p38). Activated
    MAPKs translocate to the nucleus and activate AP‐1 transcription factor resulting
    transcription of genes involved in inflammatory response. C, Apoptosis pathway.
    NODs have been reported to interact with the apoptotic pathway indirectly through
    IAP family of proteins (cIAP1, cIAP2, and XIAP) and proapoptotic protein Bid.
    D, Inflammasome activation. NODs associate with several other NLRs (NLRP1 and
    NLRP3) to form inflammasome protein complexes. After detection of their cognate
    ligand, NLRs interact with ASC protein and procaspase‐1, resulting in formation
    of inflammasomes. Once formed, inflammasomes activate procaspase‐1, which in turn
    proteolytically processes pro‐inflammatory cytokines IL‐1β and IL‐18. E, Autophagy.
    Activated NODs recruit the autophagy protein ATG16L1 to the cell membrane and
    facilitate the formation of autophagosome around invading bacteria. F, Antiviral
    response. Viral ssRNA activates NOD2, which translocates to the mitochondria and
    supposedly binds to MAVS. This promotes formation of a complex with TBK1 and IKKα,
    which enables activation of interferon regulatory factor (IRF) 3 resulting in
    production of IFN type I. ASC, apoptosis‐associated speck‐like protein containing
    caspase recruitment domain; CARD, caspase recruitment domain; cIAP, cellular inhibitor
    of apoptosis protein; ERK, extracellular signal‐regulated kinase; IAP, inhibitor
    of the apoptosis; iE‐DAP, d‐glutamyl‐meso‐diaminopimelic acid; IFN, interferon;
    IKK, IκB kinase; IκB, protein inhibitor of NF‐κB; IL, interleukin; JNK, c‐Jun
    N‐terminal kinase; NOD, nucleotide‐binding oligomerization domain; NF‐κB, nuclear
    factor κB; MAPK, mitogen‐associated protein kinase; MAVS, mitochondrial antiviral
    signaling; MDP, muramyl dipeptide; NEMO, nuclear factor κB essential modulator;
    NLRs, nucleotide‐binding oligomerization domain‐like receptors; PGN, peptidoglycan;
    RIPK2, receptor‐interacting serine/threonine‐protein kinase 2; TAB, transforming
    growth factor binding protein; TAK1, transforming growth factor β‐activated kinase
    1; TBK1, TRAF‐associated nuclear factor‐κB activator–binding kinase 1; TRAFs,
    tumor necrosis factor receptor–associated factors; XIAP, X‐linked inhibitor of
    apoptosis protein [Color figure can be viewed at wileyonlinelibrary.com]
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOS
  - FOSB
  - IRF3
  - MAPK8
  - MAPK9
  - MAPK14
  - MAPK1
  - MAPK3
  - MAPK10
  - MAPK11
  - GIF
  - MAVS
  - IKBKG
  - NOD1
  - NOD2
  - FOSL2
  - JUN
  - JUNB
  - JUND
  - FOSL1
  - ATG16L1
  - BID
  - MAPK13
  - MAPK12
  - CASP1
  - CASP2
  - CASP3
  - CASP4
  - CASP5
  - CASP6
  - CASP7
  - CASP8
  - CASP9
  - CASP10
  - CHUK
  - CASP14
  - CDK9
  - TBK1
  - XIAP
  - CASP12
  - OPRPN
  - RIPK2
  - TAB1
  - MDP
  - NACH
  - NACHT
  - XIAP CIAPS
genes:
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: INF
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: MAVS
  symbol: MAVS
  source: hgnc_symbol
  hgnc_symbol: MAVS
  entrez: '57506'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: NOD1
  symbol: NOD1
  source: hgnc_symbol
  hgnc_symbol: NOD1
  entrez: '10392'
- word: NOD2
  symbol: NOD2
  source: hgnc_symbol
  hgnc_symbol: NOD2
  entrez: '64127'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: ATG16L1
  symbol: ATG16L1
  source: hgnc_symbol
  hgnc_symbol: ATG16L1
  entrez: '55054'
- word: Bid
  symbol: BID
  source: hgnc_symbol
  hgnc_symbol: BID
  entrez: '637'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: IKKa
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: TAK
  symbol: TAK
  source: hgnc_alias_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: TBK1
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: XIAP
  symbol: XIAP
  source: hgnc_symbol
  hgnc_symbol: XIAP
  entrez: '331'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: pro-L-1
  symbol: PROL1
  source: hgnc_prev_symbol
  hgnc_symbol: OPRPN
  entrez: '58503'
- word: RIPK2
  symbol: RIPK2
  source: hgnc_symbol
  hgnc_symbol: RIPK2
  entrez: '8767'
- word: TAB1/23
  symbol: TAB1
  source: hgnc_symbol
  hgnc_symbol: TAB1
  entrez: '10454'
chemicals:
- word: MDP
  source: MESH
  identifier: C041058
- word: NACH
  source: ''
  identifier: ''
- word: NACHT
  source: MESH
  identifier: C416503
diseases:
- word: XIAP CIAPS
  source: MESH
  identifier: C564469
figid_alias: PMC6767550__F2
redirect_from: /figures/PMC6767550__F2
figtype: Figure
---
